Autoimmunity Panels: Needs and Implementation in the Underdeveloped Regions and how to Approach the Disparities.

This article discusses the importance of autoimmunity panels in diagnosing and treating movement disorders caused by autoimmune conditions. The diagnosis of antibody-related movement disorders is based on serum and CSF analysis, and there are various techniques for assessing the presence of antibodies. However, these tests are generally expensive and may only be available in larger centers or referral units. In underdeveloped regions, the availability of autoimmune panels is limited, and the cost and timing of testing can be a barrier to early diagnosis and treatment. The article suggests that widespread education of neurologists is necessary to recognize the classic phenotypes of autoimmune movement disorders and that more funding should be made available for investigations and therapies. [Extracted from the article]